Related Experiment Videos
Sequential changes in glutamate transporter protein levels during Fe(3+)-induced epileptogenesis
1Department of Psychiatry, Miyazaki Medical College, Miyazaki-Gun, Kihara 5200, Kiyotake-cho, Miyazaki, Japan. usan@post1.miyazaki-med.ac.jp
Epilepsy Research
|April 20, 2000
Summary
Iron injection in rats triggers recurrent seizures by altering glutamate transporters. Specifically, EAAC-1 increased, while GLT-1 and GLAST showed complex changes, suggesting impaired glutamate transport contributes to iron-induced epilepsy.
Area of Science:
- Neuroscience
- Epilepsy Research
- Neurochemistry
Background:
- Severe head injuries can lead to epilepsy, often associated with brain hemorrhage.
- Iron, a component of hemoglobin, can induce lipid peroxidation and seizures when injected into the brain.
Purpose of the Study:
- To investigate if altered extracellular glutamate regulation contributes to chronic epilepsy after iron-induced seizures.
- To examine the expression levels of key glutamate transporter proteins (GLT-1, GLAST, EAAC-1) in the hippocampus following iron microinjection.
Main Methods:
- Rats received ferric cation microinjections into the amygdala to induce seizures.
- Expression of glutamate transporter proteins (GLT-1, GLAST, EAAC-1) was measured in ipsilateral and contralateral hippocampi at various time points post-injection.
Main Results:
- The neuronal glutamate transporter EAAC-1 was elevated bilaterally up to 30 days post-injection.
- The glial transporter GLT-1 increased contralaterally at 5 and 15 days, returning to baseline by 30 days.
- GLAST levels initially increased but were down-regulated at 15 and 30 days, coinciding with spontaneous seizure activity.
Conclusions:
- Iron-induced epileptogenesis involves significant alterations in glial glutamate transport mechanisms.
- These transporter changes may lead to excitotoxicity and enhanced neuronal excitation within the hippocampus, promoting chronic seizures.